The biology of SARS-CoV-2 and epidemiological analysis of COVID-19 pandemic in Nigeria
DOI:
https://doi.org/10.3855/jidc.14467Keywords:
Pandemic, COVID-19, Coronavirus, epidemiology, pathogenesis, NigeriaAbstract
The pandemic triggered by SARS-CoV-2 continuous to pose a global health threat, with cases of new infections and deaths still occurring despite increasing vaccination efforts. As in other regions of the world, the pandemic has led to unprecedented stretch of health and economic systems in countries in Africa. Nigeria, the most populous African country, has not been spared as the number of new infections continues to teeter amid a high level of vaccination hesitancy. Here, we provided a brief look at the background and biology of the virus. We also highlighted the epidemiology of the virus in Nigeria, as well as the challenges and opportunities it presents. Our review will add to the knowledge of SARS-CoV-2 and the situation of the pandemic in Nigeria, and provide a better response to the pandemic and future pandemics.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).